ABBV vs PSTV

AbbVie Inc. (ABBV) is a well-established mega-cap pharmaceutical company with a robust product portfolio, strong financial health, and a leading position in key therapeutic areas. It excels as a stable dividend payer and a defensive holding. However, its fundamental characteristics, including its immense market capitalization ($397.29B), the mature nature of the pharmaceutical industry, high R&D c...

Plus Therapeutics (PSTV) retains its high-risk, high-reward profile, but its immediate financial health has significantly improved since the last analysis. The company's cash position increased to over $16 million in 2025, moving stockholders' equity from negative to positive $3.9 million, substantially extending its cash runway. This addresses the primary financial risk previously identified. Fur...